Global Medical Gas Market - 2025-2033

The global medical gas market reached US$ 18.98 billion in 2024 and is expected to reach US$ 68.31 billion by 2033, growing at a CAGR of 13.6% during the forecast period 2025-2033.

Medical gas is a specialized category used in various medical applications, including therapeutic, diagnostic, and pharmaceutical. It includes oxygen, nitrous oxide, carbon dioxide, helium, nitrogen, and medical air. Oxygen is used for respiratory support in conditions like COPD and hypoxemia, while nitrous oxide is used as an anaesthetic in surgical procedures. Carbon dioxide is crucial for insufflation during minimally invasive surgeries, and helium is used in respiratory treatments.

Nitrogen is essential in cryopreservation and medical research, while medical air is used in ventilators and patient care environments. The demand for medical gases has increased due to respiratory diseases, surgical techniques, and the expanding home healthcare sector. The market is expected to grow globally due to innovations in gas delivery systems and healthcare infrastructure.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Respiratory Disorders

The growth of the pure medical gases market is driven by the increasing prevalence of respiratory diseases like COPD, asthma, and sleep apnea. The demand for high-purity medical gases is also increasing due to the growing elderly population, pollution levels, industrial emissions, and higher smoking rates. The expansion of healthcare facilities, home care services, and advancements in gas delivery systems are crucial for the widespread adoption of pure medical gases for respiratory treatments.

For instance, Chronic respiratory diseases (CRDs), including COPD, asthma, lung cancer, and occupational lung diseases, are significant global health issues affecting 550 billion adults and accounting for 7% of all deaths. Lung cancer contributes to another 1.4 billion deaths annually. Children under five are particularly affected by lung diseases, with asthma being the most common chronic condition. Despite a 40% increase in prevalence between 1990 and 2017, CRDs have received less attention than other NCDs.

Hence, the increasing prevalence of chronic respiratory diseases (CRDs) drives demand for medical gases like oxygen therapy and inhaled treatments, with increased healthcare investments and awareness in CRD management.

Stringent Regulatory Requirements

The strict regulations on the production, storage, and transportation of pure medical gases, set by organizations like the FDA, USP, and ISO, are posing a significant challenge to market growth, potentially limiting new player entry and affecting market expansion.

Segment Analysis

The global medical gas market is segmented based on product type, application, end-user, and region.

Product Type:

The pure gases from product type segment is expected to dominate the medical gas market with the highest market share

The pure gases from the product type segment are expected to dominate the medical gas market with the highest market share.

Pure gases, including oxygen, nitrogen, nitrous oxide, carbon dioxide, and helium, are high-purity, single-component gases used in therapeutic applications, anaesthesia, respiratory treatments, diagnostic imaging, and pharmaceutical manufacturing due to their unique physiological and chemical properties.

The demand for pure medical gases is increasing due to respiratory disorders like COPD and asthma, surgical procedures requiring anaesthesia gases, and biotechnology and pharmaceutical research applications.

Advancements in gas delivery systems, stringent regulatory standards, and the growing adoption of home healthcare services fuel market growth. For instance, in October 2023, Bausch + Lomb Corporation launched its Pure-line gas range in Europe, available in pure or premixed iterations of SF6, C2F6, and C3F8. This is the latest addition to the company's surgical retina portfolio, which includes intraocular dyes for posterior and anterior staining, as well as intraocular dyes for anterior staining.

Geographical Analysis

North America is expected to hold a significant position in the medical gas market with the highest market share

North America is expected to hold a significant position in the medical gas market with the highest market share. The North American medical gas market is fueled by rising respiratory diseases, geriatric populations, and surgical procedures requiring anaesthesia gases. Also, Regulatory support and stringent safety standards ensure the widespread adoption of medical gas systems in hospitals, ambulatory surgical centres, and research facilities.

Moreover, significant partnerships, advancements in healthcare infrastructure, and expanding home healthcare services contribute to market growth. For instance, in March 2025, Meritus Gas Partners partnered with Oxygen Service Company, a leading independent distributor of packaged gases and welding supplies based in Saint Paul, Minnesota. OSC, a 100% employee-owned company, offers a wide range of products and services, including industrial, specialty, and medical gases, automation equipment, and welding and safety supplies.

Competitive Landscape

The major global players in the medical gas market include Air Liquide, Linde plc, Air Products and Chemicals, Inc., Messer Group GmbH, SOL Group, Matheson Tri-Gas, Inc., Atlas Copco, GCE Group, Nova Gas Technologies, and Gruppo SIAD, among others.

Key Developments

• In January 2025, INOX Air Products, India's largest industrial gases manufacturer, inaugurated the country's first ultra-high purity electronic grade nitrous oxide plant in Manali, Chennai, with a capacity of 1,700 tonnes per annum, ensuring high purity.
• In July 2024, Adenia Partners acquired Air Liquide's operations in 12 African countries, forming Erium, the first pan-African leader in industrial and medical gases. Erium will replace Air Liquide in Benin, Burkina Faso, Cameroon, Congo, Cote d'Ivoire, Gabon, Ghana, Madagascar, Mali, the Democratic Republic of Congo, Senegal, and Togo.

Why Purchase the Report?

• Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global medical gas market report delivers a detailed analysis with 62 key tables, more than 55 visually impactful figures, and 165 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.